Discordant HER2/Neu Status of Breast Cancer.

National Cancer Institute, Thailand

Status: Completed

Conditions: Malignant Neoplasm of Breast.

Study type: Observational

Funder types: Other

Identifiers

NCT01935739

30_2013RC_IN318

Details and patient eligibility

About

The purpose of this study is to determine discordant HER2/neu status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.

Full description

HER2/neu status of primary breast tumor and axillary lymph nodes were tested by IHC staining. In the cases of equivocal result of IHC, FISH test were performed.

The result of HER2/neu status between primary breast tumor and axillary lymph node were analyzed.

Enrollment: 105 patients

Sex: Female

Ages: 25 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Breast cancer patients stage I,II and III with axillary lymph nodes metastasis.

Exclusion criteria

• Breast cancer patients stage I,II and III without axillary lymph nodes metastasis.

Trial design

105 participants in 2 patient groups

Primary Breast Tumor

Description:

Primary breast tumor were test for HER2/neu status.

Axillary Lymph Nodes.

Description:

Axillary Lymph Nodes were tested for HER2/neu status.